Tweet
Aperio Group LLC raised its position in shares of LifePoint Health Inc (NASDAQ:LPNT) by 7.8% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 77,935 shares of the company's stock after acquiring an additional 5,620 shares during the period. Aperio Group LLC owned approximately 0.20% of LifePoint Health worth $3,803,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also recently bought and sold shares of LPNT. Chicago Equity Partners LLC bought a new position in shares of LifePoint Health in the first quarter worth about $953,000. Point72 Asset Management L.P. bought a new position in shares of LifePoint Health in the first quarter worth about $21,489,000. Profit Investment Management LLC bought a new position in shares of LifePoint Health in the second quarter worth about $2,448,000. James Investment Research Inc. bought a new position in shares of LifePoint Health in the second quarter worth about $1,778,000. Finally, American Century Companies Inc. grew its holdings in shares of LifePoint Health by 4.0% in the first quarter. American Century Companies Inc. now owns 4,387,747 shares of the company's stock worth $206,224,000 after purchasing an additional 167,157 shares during the last quarter. Get LifePoint Health alerts:
Shares of LifePoint Health stock opened at $64.50 on Friday. The company has a current ratio of 1.85, a quick ratio of 1.63 and a debt-to-equity ratio of 1.27. LifePoint Health Inc has a 1 year low of $41.45 and a 1 year high of $65.35. The stock has a market cap of $2.50 billion, a price-to-earnings ratio of 17.77, a price-to-earnings-growth ratio of 1.34 and a beta of 0.71. LifePoint Health (NASDAQ:LPNT) last issued its earnings results on Friday, July 27th. The company reported $1.27 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.08 by $0.19. LifePoint Health had a net margin of 0.65% and a return on equity of 7.04%. The company had revenue of $1.57 billion for the quarter, compared to analysts' expectations of $1.58 billion. During the same period in the prior year, the business earned $0.96 EPS. The firm's quarterly revenue was down 1.6% on a year-over-year basis. equities research analysts forecast that LifePoint Health Inc will post 4.59 earnings per share for the current fiscal year.
A number of research firms have recently commented on LPNT. BidaskClub cut shares of LifePoint Health from a "hold" rating to a "sell" rating in a report on Thursday, August 9th. Zacks Investment Research cut shares of LifePoint Health from a "hold" rating to a "sell" rating in a report on Tuesday, July 24th. Credit Suisse Group upped their price target on shares of LifePoint Health from $58.00 to $65.00 and gave the stock a "neutral" rating in a report on Tuesday, July 24th. BMO Capital Markets upped their price target on shares of LifePoint Health from $62.00 to $65.00 and gave the stock a "market perform" rating in a report on Tuesday, July 24th. Finally, Robert W. Baird cut shares of LifePoint Health from an "outperform" rating to a "neutral" rating and set a $74.00 price target on the stock. in a report on Tuesday, July 24th. Three research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have assigned a buy rating to the company. LifePoint Health has an average rating of "Hold" and an average target price of $58.73.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery